Literature DB >> 15626887

NOD2/CARD15 mutations and presence of granulomas in pediatric and adult Crohn's disease.

Ron Shaoul1, Amir Karban, Batia Weiss, Shimon Reif, Dror Wasserman, Avi Pacht, Rami Eliakim, Joram Wardi, Haim Shirin, Eitan Wine, Esther Leshinsky-Silver, Arie Levine.   

Abstract

OBJECTIVES: The etiology and mechanism leading to granuloma formation in patients with Crohn's disease (CD) are presently unknown. The first susceptibility gene to be identified as a risk factor for CD is the NOD2/CARD15 gene on Chromosome 16. Mutations in NOD2 could affect the intracellular response to bacterial products and may eventually lead to granuloma formation. The association between NOD2 and granulomas has not been previously explored. We evaluated a possible association between NOD2 mutations and granuloma formation, and compared the prevalence of granulomas in both pediatric and adult cohorts.
METHODS: Patients were consecutively recruited through pediatric gastroenterology and adult gastroenterology programs. Patients were eligible if CD was confirmed, and they had undergone full colonoscopy with biopsy and/or surgical resection. Patients underwent genotyping for NOD2 disease-associated mutations.
RESULTS: A total of 230 patients were enrolled into the study, of whom 169 patients met all inclusion/exclusion criteria (Group 1, 77 patients [age range 1-16 years]; Group 2, 92 patients [age range 17-68 years]). Surgical resection was performed more often in adults (P < 0.005), and gastroscopy was performed more frequently in children (P < 0.001). Granulomas were found in 34% of the patients studied. The prevalence of granulomas did not differ by age, age group, or gender. A disease-associated NOD2 mutation was found in 37.8% of patients. Granulomas were found in 39% of patients with NOD2 mutations compared with 31% of those without NOD 2 mutations (difference was not significant). In addition, no difference was noted for the specific mutations.
CONCLUSIONS: We did not find any correlation between NOD2 mutations and granuloma formation. The cause of granulomas in CD remains elusive.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15626887     DOI: 10.1097/00054725-200411000-00003

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

Review 1.  Role of intestinal mucins in innate host defense mechanisms against pathogens.

Authors:  Poonam Dharmani; Vikas Srivastava; Vanessa Kissoon-Singh; Kris Chadee
Journal:  J Innate Immun       Date:  2008-10-08       Impact factor: 7.349

2.  Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's disease.

Authors:  Kelli L VanDussen; Ta-Chiang Liu; Dalin Li; Fadi Towfic; Nir Modiano; Rachel Winter; Talin Haritunians; Kent D Taylor; Deepti Dhall; Stephan R Targan; Ramnik J Xavier; Dermot P B McGovern; Thaddeus S Stappenbeck
Journal:  Gastroenterology       Date:  2013-09-25       Impact factor: 22.682

3.  Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

4.  Analysis of the interleukin-12/interferon-gamma pathway in children with non-tuberculous mycobacterial cervical lymphadenitis.

Authors:  Francis Serour; Avraham Mizrahi; Eli Somekh; Jacqueline Feinberg; Capucine Picard; Jean-Laurent Casanova; Ilan Dalal
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

Review 5.  Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.

Authors:  Gian Eugenio Tontini; Maurizio Vecchi; Luca Pastorelli; Markus F Neurath; Helmut Neumann
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

6.  Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases.

Authors:  S Cucchiara; A Latiano; O Palmieri; A M Staiano; R D'Incà; G Guariso; G Vieni; V Rutigliano; O Borrelli; M R Valvano; V Annese
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

7.  Disease behavior in children with Crohn's disease: the effect of disease duration, ethnicity, genotype, and phenotype.

Authors:  Ron Shaoul; Amir Karban; Shimon Reif; Batia Weiss; Raanan Shamir; Ada Tamir; Ofir Davidovich; Jonathan Halevi; Esther Leshinsky Silver; Arie Levine
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

8.  Established genetic risk factors do not distinguish early and later onset Crohn's disease.

Authors:  Jonah B Essers; Jessica J Lee; Subra Kugathasan; Christine R Stevens; Richard J Grand; Mark J Daly
Journal:  Inflamm Bowel Dis       Date:  2009-10       Impact factor: 5.325

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.